Physician profile
Samith Sandadi
NPI 1790980142
$28,038.98
in general payments reported to CMS, 2019-2025
29 companies · $405 in 2025
The $405 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $2,056 · 2021: $2,708 · 2022: $807 · 2023: $780 · 2024: $632 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,817.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,066.06 | 2019-2021 | |
| Tesaro, INC. | $5,973.95 | 2019 | |
| Glaxosmithkline, LLC. | $946.07 | 2019-2025 | Zejula, Jemperli |
| Merck Sharp & Dohme LLC | $652.11 | 2019-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals Lp | $646.36 | 2019-2025 | Lynparza |
| Eisai INC. | $426.32 | 2020-2025 | |
| Clovis Oncology, INC. | $397.87 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $317.59 | 2020-2025 | Precisetumor, Myrisk |
| Baxter Healthcare | $288.35 | 2021-2024 | Tisseel, Perclot |
| Abbvie INC. | $234.75 | 2019-2025 | |
| Ethicon US, LLC | $214.68 | 2019-2023 | Enseal |
| Seagen INC. | $212.30 | 2021-2023 | Tivdak |
| Medical Device Business Services, INC. | $203.34 | 2021-2022 | |
| Genentech USA, INC. | $77.81 | 2019 | |
| Pfizer INC. | $75.56 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $41.25 | 2024-2025 | Xt Cdx |
| Momentis Surgical INC. | $40.00 | 2022 | |
| Distalmotion US | $25.80 | 2025 | Dexter L6 Robot |
| Immunogen, INC. | $23.32 | 2023 | Elahere |
| Kci USA, INC. | $21.91 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $20.73 | 2025 | Exparel |
| Novartis Pharmaceuticals Corporation | $19.78 | 2023 | |
| Caris Mpi, INC. | $19.61 | 2025 | Mi Cancer Seek |
| Fennec Pharmaceuticals, INC. | $17.11 | 2025 | Fyarro |
| Medtronic, INC. | $17.07 | 2023 | Linq II |
| Solventum Corporation | $15.22 | 2024 | Prevena |
| Hologic Sales and Service, LLC | $15.16 | 2020 | |
| Coopersurgical, INC. | $14.93 | 2021 | |
| Teleflex LLC | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samith Sandadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.